Your Vault RIM Was Optimized at Go-Live. Is It Optimized Today?

Your Vault RIM Was Optimized at Go-Live. Is It Optimized Today?

When organizations implement Veeva Vault RIM, tremendous effort goes into designing the right solution. Business processes are mapped, security is carefully configured, workflows are established, integrations are built, and governance models are defined. Months of planning culminate in a platform designed to support the organization’s regulatory operations for years to come.

But no organization stands still.

Regulations evolve. The business grows through acquisitions. New products enter development. Organizational structures change. Administrators respond to new requests, implement enhancements, adjust security, and introduce new processes to meet immediate business needs. Meanwhile, Veeva continues to release new capabilities three times each year, providing opportunities to improve efficiency, simplify administration, and enhance regulatory operations.

Each of these decisions is reasonable on its own. Collectively, however, they can gradually move the platform away from the environment that was originally designed.

The Hidden Cost of Platform Drift

Enterprise software doesn’t usually fail because of one poor decision. Instead, it evolves through hundreds of small decisions made over many years.

    • A configurable feature isn’t enabled because it isn’t immediately needed.
    • A custom workflow is built to address a business requirement that existed at the time.
    • Security permissions become increasingly granular as new teams and responsibilities are added.
    • Manual processes remain in place because “that’s how we’ve always done it.”

Each decision solves a legitimate problem. The challenge is that very few organizations periodically step back to ask whether those decisions still make sense today.

The result is what we call platform drift: the gradual accumulation of configuration changes, administrative decisions, and business adaptations that slowly move the platform away from its most efficient and maintainable state.

Yesterday’s Decisions May Limit Tomorrow’s Capabilities

One of the greatest strengths of Veeva Vault RIM is its continuous innovation. Every year, Veeva delivers new functionality designed to improve regulatory operations, automate manual activities, and help organizations respond to changing regulatory requirements. Many of these capabilities build upon configuration options or foundational features that may have been available for years.

Organizations often discover that decisions made during the original implementation now influence their ability to adopt those newer capabilities.

    • A configurable feature was left disabled because there was no immediate business value at the time.
    • A highly customized workflow solved an earlier challenge but now duplicates standard product functionality.
    • An increasingly complex security model makes routine administration more difficult than necessary.

None of these situations indicates a poor implementation. They simply reflect the reality that both the business and the software have evolved. Without periodically reassessing the platform, organizations can unknowingly miss opportunities to simplify operations, improve user adoption, and gain more value from capabilities they already own.

More Features Don’t Always Mean More Value

Many organizations assume they’re getting maximum value simply because they’re running the latest version of Vault RIM. Version currency, however, is only part of the equation.

Real platform maturity depends on questions such as:

    • Are we taking advantage of the capabilities available to us?
    • Have our business processes become unnecessarily complex over time?
    • Is our security model enabling collaboration or creating administrative overhead?
    • Is our regulatory data organized consistently and supporting efficient operations?
    • Are users relying on manual workarounds that newer functionality could eliminate?
    • Does our documentation still reflect how the system actually operates?

These are business questions, not simply technical ones. Answering them requires an objective assessment of how the platform supports today’s organization rather than the organization that existed at go-live.

A Health Check Should Look Beyond Technology

An effective platform assessment should evaluate more than configuration settings. It should examine how people, processes, governance, and technology work together to support regulatory operations.

HealthCheckAssist was developed specifically for that purpose.

Through stakeholder interviews, feature utilization reviews, data and document organization assessments, security evaluations, and training and documentation reviews, HealthCheckAssist provides organizations with an objective understanding of how effectively their Vault RIM environment supports current business needs.

Rather than producing a list of technical observations, the assessment identifies opportunities to improve solution utilization, reduce administrative complexity, strengthen governance, improve data quality, and develop a practical roadmap for future optimization.

Making the Most of Your Investment

Implementing Vault RIM represents a significant investment of time, resources, and organizational effort.

The objective shouldn’t simply be to keep the system running. It should be to ensure the platform continues to evolve alongside the business, enabling users to take advantage of new capabilities, reducing unnecessary complexity, and supporting efficient regulatory operations for years to come.

The best-performing organizations recognize that optimization is not a one-time implementation activity. It is an ongoing process of evaluating whether yesterday’s decisions still support today’s business objectives.

If it has been several years since your Vault RIM environment was assessed, now may be the right time to ask a simple question: Is your platform still optimized? Or has it gradually drifted away from its full potential?

Learn how HealthCheckAssist can help your organization evaluate its Vault RIM environment, identify optimization opportunities, and maximize the value of your investment by downloading the datasheet below.

Why RIM Modernization Projects Succeed or Fail BEFORE Vendor Selection

Why RIM Modernization Projects Succeed or Fail BEFORE Vendor Selection

Selecting a new Regulatory Information Management (RIM) platform is one of the most significant technology decisions a Life Sciences organization will make. The chosen platform will influence regulatory operations, compliance, data governance, and business agility for years to come.

As organizations expand product portfolios, enter new markets, and adapt to evolving regulatory requirements, many begin asking the same question: Does our current RIM environment still support our business, or is it time to modernize?

Organizations quickly discover that selecting a platform is only one part of a much larger challenge..

The Greatest Risks Are Organizational, Not Technical

Most regulatory organizations recognize the challenges limiting operational efficiencies. Regulatory data is spread across multiple systems, reporting requires significant manual effort, and teams follow different processes across regions or business units. The result is inconsistent information, limited visibility, and reduced confidence in regulatory operations.

While these issues often appear to be technology limitations, they are typically the result of years of organizational evolution. As companies expand into new markets, acquire products, adapt to changing regulations, and grow their teams, processes naturally evolve. Local workarounds emerge, governance practices drift, and information is managed differently across functions and regions. Over time, this complexity becomes embedded within the technology landscape itself.

These inconsistencies often remain hidden until requirements gathering or implementation activities begin. At that point, differences between teams, regions, and business units become impossible to ignore. New software alone cannot resolve these underlying challenges. Because regulatory information supports product planning, market expansion, compliance, and strategic decision-making, inconsistent processes and unreliable data quickly become business risks.  

The objective is not simply to replace technology; it is to modernize how people, processes, information, and technology work together. Achieving this requires a different approach.

Change Your Focus: Goals, Not Feature Lists

Successful modernization begins by asking a different question. Instead of asking which platform has the best capabilities, organizations should ask what they are trying to achieve. Without clearly defined future-state objectives, teams become focused on vendor demonstrations, feature comparisons, and technical evaluations rather than business outcomes they need to deliver.

The most successful organizations first understand their current state, identify operational inefficiencies, define future capabilities, and engage stakeholders across Regulatory Affairs, Regulatory Operations, IT, and business leadership. This confirms modernization goals reflect enterprise priorities rather than the needs of a single function.

With this foundation in place, technology is evaluated against business objectives, not feature checklists, resulting in solutions that support long-term regulatory strategy rather than simply replacing existing systems.

SelectAssist℠: Proven Structure for a Complex Decision

Few organizations undertake RIM modernization frequently enough to develop a repeatable approach. Regulatory leaders may oversee one or two major platform transformations during their careers, yet the decisions they make influence operations for years.

SelectAssist was developed by fme to help Life Sciences organizations navigate these decisions through a structured, vendor-neutral methodology. Through executive interviews, stakeholder workshops, process and governance assessments, current-state analysis, and business case development, we establish a clear understanding of your organization’s operating model, future-state objectives, and critical business requirements.

Using this foundation, we objectively evaluate and score RIM platforms against your defined criteria, providing leadership with a clear understanding of each solution’s strengths, tradeoffs, risks, and long-term fit. Rather than selecting technology based on demonstrations or feature lists, organizations make informed decisions aligned with their regulatory strategy, operating model, and future growth.

Because successful modernization depends on more than technology, SelectAssist also evaluates the people, processes, governance, data, and organizational readiness required to support a successful transformation.

If your organization is evaluating a new RIM platform, or simply wants confidence that it is asking the right questions before engaging software vendors, we’d welcome the opportunity to discuss your modernization goals. Download the SelectAssist datasheet to learn how our proven methodology helps Life Sciences organizations make informed, objective platform decisions with confidence.


About the Author

Meghan Carr, PMP

Meghan Carr, PMP, is Vice President of Commercial Operations at fme Life Sciences, leading global commercial strategy for regulated content and data modernization initiatives across the pharmaceutical and biotechnology industries. With more than 20 years of experience spanning Regulatory, Clinical, and Quality, she has worked with many of the world’s leading life sciences organizations on complex digital transformation programs.

Throughout her career with leading global software vendors, implementation partners, and technology service providers, Meghan has supported hundreds of technology evaluations, proposals, and transformation initiatives. This experience has provided a unique perspective on the platform selection process and the organizational factors that ultimately determine modernization success.

Join fme at the Pharmaceutical Manufacturing World Summit

Join fme at the Pharmaceutical Manufacturing World Summit

Every year, the Pharmaceutical Manufacturing World Summit in Boston brings together industry leaders, innovators, and manufacturing experts to explore the future of pharmaceutical production. As both attendees and sponsors, the fme team enjoys this unique opportunity to engage in meaningful conversations, exchange insights, and advise on the technology and data management strategies that shape Life Sciences manufacturing today. Many of the key themes that defined last year’s agenda continue to be critical topics within the industry.

Key Themes Shaping Pharmaceutical Manufacturing World Summit

Year after year, one common thread unifies the agenda: Data is the foundation of transformation for business success.

Whether enabling AI, supporting regulatory compliance, or driving operational efficiency, success depends on having trusted, structured, and accessible data across the product lifecycle. Here are some of the recent areas of focus we’ve repeatedly shared with our clients:

ECM Platform ServicesData as a Strategic Asset

One of the most important points of the conference is data is no longer just operational, it’s transformational. Organizations are increasingly relying on high-quality, accessible data to drive decision-making across supply chains, manufacturing performance, and patient safety.

The ability to treat data as a strategic asset rather than a byproduct has finally been recognized as a competitive differentiator, and has been fme’s focus and mission for over 25 years. We help companies maximize the value and power of their data, ensuring it is structured, reusable, and ready to migrate into powerful solutions that unlock its full value across the enterprise.

digital_infrastructure

Navigating Geopolitical Uncertainty

Global manufacturing strategies are being reshaped by shifting regulatory landscapes, trade policies, and geopolitical tensions. From increased pressure to localize production in the U.S. to evolving FDA leadership and AI regulation, companies are operating in an environment of heightened uncertainty and risk.

fme helps guide organizations through the dynamic data management challenges that can affect supply chain resilience, inspection readiness, and compliance strategies.

Infrastructure Investment and Digital Transformation

The scale of investment in modern manufacturing infrastructure is staggering. Leading pharmaceutical companies are building digitally native, highly automated facilities designed for flexibility, speed, and advanced modalities like cell and gene therapies.

Technologies such as digital twins, robotics, IIoT, and integrated MES/QMS platforms are becoming foundational. At the same time, organizations are recognizing that less than 1% of process data is often fully utilized, highlighting a major opportunity for transformation.

To ensure technology investments address both immediate and long-term needs, it is critical to work with a technology partner that understands the technical and business goals of an integrated research, development, and manufacturing pipeline.

Pricing Pressures Driving Efficiency

With rising costs across the industry, manufacturers are under pressure to do more with less. The focus has shifted toward reducing inefficiencies, eliminating rework, and accelerating system consolidation.

This is where digital enablement and automation powered by clean, high-integrity data are playing a critical role in turning compliance into a value-generating function rather than a cost center.

Innovation Accelerating at Scale

From AI-driven quality transformation to novel manufacturing platforms, innovation is rapidly reshaping the industry.

Highlights from last year included:

  • AI-enabled quality systems and predictive manufacturing
  • Expansion into advanced modalities like ADCs and cell therapies
  • End-to-end digital supply chain orchestration
  • Increasing use of GenAI to enhance quality and operational efficiency

Organizations are not just experimenting. They are scaling these innovations to drive measurable business outcomes before their competition.

Join Us at This Year’s Summit

We’re excited to return to the Pharmaceutical Manufacturing World Summit this year as a sponsor and continue the conversation with industry leaders.

If you’ll be attending, we’d love to connect! Contact us and we’ll schedule a time to discuss your current challenges, share our proven strategies and insights, or explore how to accelerate your digital and data initiatives. If you can’t attend and would like a summary of the essential topics and sessions, let us know.

Master Data and Governance in a New Life Sciences Reality

Master Data and Governance in a New Life Sciences Reality

We are excited to share that fme will be joining the 12th Master Data and Data Governance Excellence In Life Sciences Conference, 4-5 June in Zurich, Switzerland. In the Life Sciences industry, data is no longer just an operational asset, it is the foundation for innovation, regulatory compliance, and commercial success. fme’s experts look forward to participating in these discussions to share our experience and strategies to rescue information from disconnected silos and align it with business goals.

Today, data is no longer a by-product of operations. It is a strategic asset that underpins innovation, regulatory compliance, and commercial success.

Across Regulatory, Clinical, Quality domains, organizations are entering a new data reality. Regulatory expectations, such as IDMP, are accelerating the need for structured, standardized, and interoperable data. At the same time, governance is evolving from control to enablement, where data must actively support processes, analytics, and decision-making. In addition, new AI solutions show amazing promise but are only as effective as the data they are built on.

This shift is redefining long-standing concepts. The idea of a single, static source of truth is giving way to dynamic, connected, and context-driven data ecosystems that must work seamlessly across systems and functions.

The Gap Between Ambition and Execution

Many organizations are investing in AI use cases, data governance frameworks, and master data management initiatives. However, execution remains a challenge.

  • Data is often not AI-ready.
  • Quality issues limit trust and reuse.
  • Governance frameworks exist but are not embedded in daily operations.
  • MDM approaches struggle to scale across domains and keep pace with increasing complexity.

This creates a disconnect between strategy and reality. Without trusted and governed data, transformation initiatives slow down, risk increases, and expected value is not fully realized.

How fme Translates Data Strategy into Execution

At fme, we help Life Sciences organizations turn data ambition into execution. Our approach focuses on building trusted data foundations that support transformation across the full lifecycle:

Data readiness and assessment

We help organizations understand their data landscape through system inventory, quality analysis, and risk identification. This creates clarity before transformation begins.

Master data and governance enablement

We support the design and operationalization of governance frameworks, including data ownership, metadata standards, and harmonization across domains. The focus is on making governance actionable in daily work.

Migration and transformation execution

With deep expertise in platforms such as Veeva Vault, Generis CARA, Documentum, and TrackWise, fme delivers controlled and compliant migrations. Our migration-center® technology enables scalable, repeatable, and auditable execution.

Data quality and remediation

We support ongoing data quality improvement, remediation, and post-go-live stabilization to ensure data remains trusted, usable, and aligned with evolving requirements.

A Practical Path Forward

Success in this new data reality requires more than technology. It requires scalable governance, high-quality data, and the ability to operationalize master data across domains.

fme combines domain expertise, proven methodology, and purpose-built technology to help organizations reduce risk, improve efficiency, and unlock the full value of their data.

Meet Us at the Conference

We look forward to connecting at the 12th Master Data and Data Governance Excellence in Life Sciences Conference and discussing how Life Sciences organizations can move from ambition to execution.

If you are navigating data complexity, regulatory pressure, or AI readiness, let’s connect. We’d love to discuss your challenges, and share our proven strategies and solutions to complex information management challenges.

Your Data Isn’t Ready: The Hidden Risk in Life Sciences Migrations

Your Data Isn’t Ready: The Hidden Risk in Life Sciences Migrations

In life sciences organizations a data migration is often treated like a set of technical checklist: Extract. Map. Load. Validate. Go Live! But anyone who has worked on any data migration knows the truth:

Migration isn’t really about moving data. It’s about moving meaning.

Meaning is where things get complicated, especially when organizations underestimate the differences between structured and unstructured data. This is a common challenge we’ve seen with our clients, especially when modernizing .

The Illusion of Data Readiness

Most migration programs begin with confidence. After all, the data exists, it’s stored somewhere, it’s been used for years, so how hard can it be? Then the first mapping workshops begin… the cracks start to show:

    • Submission types or study metadata don’t match controlled vocabularies across regulatory and clinical systems
    • Status fields are full of free text: study milestones, complaint records, or CAPA statuses captured inconsistently instead of following lifecycle states
    • Product hierarchies only make sense to one team due to differing interpretations
    • Critical decisions about safety case assessments, investigation outcomes, or deviations can be, and often are, buried in comments, emails or spreadsheet notes

The issue isn’t a lack of data. It’s that years of business logic are hidden inside unstructured information. Systems can’t interpret or migrate assumptions. Suddenly this becomes a much bigger problem.

What began as a simple mapping exercise quickly becomes an effort to untangle undocumented processes, institutional knowledge, and years of historical workarounds.

Don’t worry, you are not alone. We’ve seen firsthand how quickly complexity multiplies once that hidden logic is uncovered.

Structured Data is Predictable. Unstructured Data is Personal.

Understanding the difference between structured data and then unstructured information surrounding it is critical. Structured data is easy. It lives in defined fields, it supports reporting, it drives workflows, and it can be migrated using clear, defensible mapping rules.

Unstructured data is different. It contains insight, often extremely valuable insight, but it is hidden within narrative, interpretation, and context. It hides in documents, trackers, comments, file names, or “temporary” excel sheets that quietly became the system of record.

In many life sciences organizations, the most important regulatory knowledge isn’t stored in the system. It’s stored around the system. And that’s where migrations become truly challenging!

A Simple Example

Here’s a simple, yet very common, example. Consider a site selection tracker used in a clinical program. On the surface, it looks structured. Why? The data appears well-structured:

    • Clearly defined columns (STUDY_NUMBER, SI_COUNTRY, SI_SITE, SI_SITE_STATUS)
    • A reason field (DC_REASON_NON_SELECTION)
    • Consistent row-based records

From a migration perspective, it looks like a straightforward mapping exercise.

Why It Isn’t Really Ready

Once you examine the content, key information lives in unstructured comments.

Structured fields contain conflicting information. In Record 2, SI_SITE_STATUS is selected as “Ongoing” yet the DC_REASON_NON_SELECTION field lists “Low recruitment projections.” If the site is indeed Ongoing, it raises a logical question: why does a Reason for Non-Selection exist at all? This suggests the fields are being used inconsistently, without validation rules in place, or that there is not a clearly enforced process for system use (if it is even defined). As a result, this record contains conflicted structured data, making it challenging to determine the true state of the site without manual investigation. Remember when we thought this would be a straightforward mapping exercise?

Important decisions are hidden in narrative text. In Record 3, the DC_REASON_NON_SELECTION comment is ““Site has no psychologist and stated it would be difficult to organize one. Site declined participation.” The structured field says “Does not have required staff” but the comment contains additional operational logic: it specifies a missing role (psychologist), identifies a feasibility constraint, and captures the site’s final decision. A target system cannot easily interpret or structure that information.

Multiple concepts are embedded in a single field. The comment in Record 3 actually contains several data elements all collapsed into a single free-text field:

Concept Where It Appears
Required Role Missing “no psychologist”
Operational Feasibility “difficult to organize one”
Final Decision “Site declined participation

 

Structured fields are left blank. While the explanation appears in comments! Record 4’s DC_REASON_NON_SELECTION field is blank, but the comments indicate variations like, “Site lacks sufficient experience”, “Investigator has limited trial experience”, and “Site has not conducted similar studies”.

To a human reader, these records make sense (mostly, I am looking at you, Record 2). To a system, they are entirely inconsistent. When migrated into a structured platform, Record 3 will be reportable and visible in analytics. Record 4 will not.

This is how unstructured behavior quietly undermines structured intent. This is exactly where migrations become more than technical exercises. They become exercises in data governance.

Target Systems Expose Legacy Exceptions

Today’s modern enterprise platforms (QMS, CTMS, RIM), safety databases, or regulated content management systems are built to enforce structure. They require:

    • Controlled vocabularies
    • Mandatory fields
    • Valid relationships
    • Consistent master data
    • Full traceability

That’s a good thing: it improves compliance, visibility, and efficiency. But it also reveals an uncomfortable truth: your legacy systems don’t just store data; they also store a legacy of exceptions. Those exceptions were often managed manually by experienced people, not by processes. When you migrate into a structured system, those manual workarounds suddenly have nowhere to hide.

The Real Risk: Migrating Years of Clutter

In regulated environments there’s an instinct to migrate everything “as-is.” Teams don’t want to lose audit trails, history, or critical business context. That instinct is understandable and logical. But migrating unstructured data blindly into a structured system creates a new problem: a modern platform filled with legacy clutter.

From the moment the system goes live, clutter and data exceptions affect user trust and efficiency. Technically, everything works, but users hesitate. They double-check. They export to Excel “just to be safe”. Slowly, spreadsheets start creeping back in. The migration succeeded on paper, but failed in adoption, and is no longer the trusted source of truth.

Poor data structure also prevents organizations from taking advantage of the AI and analytics capabilities built into most modern and emerging platforms. When critical information is buried in comments or captured inconsistently, systems cannot identify trends, recurring issues, or relationships between records, such as patterns across complaints, deviations, safety events, or site performance. Without structured data, the platform cannot surface insights or enable automation, reducing it to little more than a repository rather than an intelligent operational tool.

The Mindset Shift That Ensures Data Readiness

The most successful migration programs don’t ask: “How do we move everything?” They ask: “What do we need to trust on Day One?” That subtle shift changes everything, leading to smarter, more strategic decisions.

Not everything needs to become a structured field in your target system, but the meaning behind the data must remain clear and remain interpretable. One practical way we approach this with our clients, regardless of their volume of data, is by separating data into three categories early on.

    1. Workflow-critical and compliance-driving (must be structured)
    2. Contextual but still valuable (evaluate and transform selectively)
    3. Historical reference (archive with traceability)

Of course, there are other valid approaches, and each one has strengths within specific situations. The right strategy always depends on the organization, its risk profile, and its future operating model. The key is to make conscious decisions rather than defaulting to “migrate it all.”  Successful migrations treat the effort as a business transformation, not just a technical transfer.

A Simple Decision Framework for Data Migration

Here’s a simple principle that we’ve found is a great starting point:

    1. If data drives a workflow, reporting, or compliance decision, it must be structured.
    2. If data provides useful operational context, evaluate it and structure it selectively.
    3. If data provides historical reference only, it belongs in documents or a well-managed archive.

Final Thought: Don’t Just Migrate. Modernize.

Migrations rarely fail because of technology. They fail when unstructured legacy knowledge is assumed to be structured truth. Don’t fall into that trap by starting with tools and mapping spreadsheets. Start with the harder questions: What is our source of truth?  Which data do we trust enough to run the business on?

Life sciences organizations are moving toward greater automation, AI-driven insights, and real-time regulatory visibility. None of that works without reliable, structured data. The migration process should force organizations to face those questions, especially if they have been avoided for years. Once they are answered honestly and completely, migration stops being just a technology project. It becomes a transformative step toward true digital maturity.

By assessing your data landscape before you start your migration, you’ll be able to define clear ownership, and build a pragmatic strategy for what to structure, transform, or archive. Instead of a system replacement, you’ll have the opportunity to strengthen compliance, improve transparency, and lay the foundation for automation and AI.

Get Started the Right Way

We know it is tempting to jump straight into platform selection and implementation, but modernizing any complex, regulated environment will not be a simple ‘lift and shift’ to a new technology. If you try to approach it that way, you will delay your progress, multiply your workload, and fail to realize the full potential of your target system. After over two decades helping clients navigate technology transfers, fme’s experts can guarantee that “one-click export” you are promised is a beautiful story told by people who have never had to do or pay for the actual work.

Start your modernization initiative correctly with a clear and detailed analysis of your existing data and document repositories. You’ll quickly discover proprietary data formats and custom-built applications that are incompatible with modern databases and tools, siloed systems with limited integration capability, data consolidated from multiple sources with inconsistent data structures and standards, and legacy systems with redundant or incomplete data and metadata.

fme’s Migration Readiness Evaluation

fme’s Migration Readiness Evaluation service is specifically designed and proven to provide proactive guidance on your data and document landscape BEFORE embarking on extensive solution deployments. We take a hard look at the source system’s technical stack: how it was built, how accessible it is, what’s custom, what’s obsolete, and how long it’s realistically going to take to get clean, validated data out of it.

Instead of being caught unaware during your deployment, we identify potential risks and common pitfalls in a Migration Readiness Report that summarizes the current state and quality of your data and documents. We also offer Risk Mitigation Recommendations with proactive solutions to minimize potential risks and ensure you stay on time and on budget.

Download this datasheet to learn the details and benefits that fme’s Migration Readiness Evaluation can provide, and then contact us to discuss your unique challenges. We’d love to help you on your transformation journey.

About the Author

Wendy Gilhooley
Wendy Gilhooley has over 25 years of global experience delivering leading edge IT-related services and solutions in highly regulated industries. For the last 15 years Wendy has been focused on the complex challenges of life sciences firms struggling to modernize their Regulatory Information Management (RIM) systems. Her depth of knowledge allows her to bridge the gap between business and IT teams, and provide a wealth of technical and industry best practices to increase client business value and deliver measurable results.

A Smart Start To Digital Technology Transformations: The Power of Phase 0

A Smart Start To Digital Technology Transformations: The Power of Phase 0

The journey to modernize your digital technology platforms is sensitive and complex. As more companies become familiar with the intricacies and pitfalls of a digital transformation, it is becoming commonly understood that a ‘lift-and-shift’ approach to modernization is an ideal of a time gone by.

Today, companies are operating on an unprecedented scale, spanning global geographies with large expanding portfolios. The need to store, categorize and maintain healthy data has never been higher. Furthermore, this data needs to be readily accessible by related systems, workflows and people for its value to be realized and utilized.

Businesses are now looking for strategic partnerships, with a view to have a seasoned technical chaperon guide them end-to-end on their technology transformation. fme has spent over two decades helping clients navigating such waters, providing the highest standards for digital migrations.

Why You Want to Start Smart

Many companies under pressure to modernize start by looking at all the benefits the future technology can bring. This is only natural, it is one of the catalysts for change, understanding the limitations of today and looking for ways they can be relived. However, whilst looking forwards, often overlooked is the existing data and the system it lives in. Like all transformations, data readiness and compatibility is absolutely key. It will dictate the pace and complexity of the journey if not managed in a tailored and strategic manner. This leaves companies asking the question: ‘What do I actually need to do?’

Answering this call to action, fme offers initial technical and business engagement in the form of a ‘Phase 0’. This phase allows fme to leverage our in-house expertise and specialist tools to directly review your situation. With the ability to communicate the transformation requirements and complexities, we work with you to build a roadmap to suit your requirements.

The Power of Phase 0

Collaborating with fme on a Phase 0 offers a wide range of benefits for your digital transformation:

  • Produces an informed migration strategy that is bespoke to your digital transformation needs and requirements.
  • Assesses data quality and readiness, recommending actions to set your journey up for success.
  • Builds in your key stakeholder feedback, to develop a data specification that is compatible with the source and target system.
  • Shares early insights on potential challenges and how we can pre-emptively act to monitor and mitigate, reducing you overall risk.

Furthermore, we support in breaking down terminology and knowledge barriers, to support you in becoming the Champion of your own transformation journey. By demystifying the process and guiding, we look to physically and mentally set our clients up for sustainable success.

Phase 0 both de-risks the journey ahead whilst streamlining the subsequent phases to come. Whilst some unforeseeable deviations from the mapped journey may naturally occur, (e.g. Evolving client requirements) the efficiencies of operation resulting from Phase 0 allow all collaborating teams the needed time and energy to tackle such occurrences quickly and effectively.

This Is What A Smart Start Looks Like

A Phase 0 can be tailored to your schedule, typically taking a minimum of 4 weeks to complete. During this time we work with you to access your systems in compliance with your operating procedures. Whilst reviewing your source systems and data, we will host a series of workshops to discuss data quality, migration needs and how this will happen.

You will receive our findings, assessments and recommendations throughout Phase 0, all of which is documented in a comprehensive set of tangible deliverables. Typically, this includes:

  • Data Migration Strategy – Explains how your data migration will be performed sensitive to your requirements, complete with a verification strategy and timeline.
  • Preliminary Data Quality Assessment – Shares key insights on data health, migration readiness, recommended corrective actions to support the migration and broader transformation journey.
  • Preliminary Data Specification – Documents data stored per source and its intended target area, details classifications/notations and where they will differ between the source and target and proposes logical migratory paths.
  • Migration Phase 1 Scope of Work and Budget – Informed by the Phase 0 findings, outlines the activities and costs needed to successfully complete your data migration.

As your strategic partner, all findings are discussed with you directly to ensure the transfer of knowledge is maximised. We will then review this documentation, based on your feedback to further hone its accuracy; just another way we hope to further empower our clients.

Final Thoughts In A Nutshell

Phase 0 provides you with a clear project roadmap, that has an informed strategy and communicable project plan. This both de-risks the complex journey ahead whilst simplifying the subsequent phases to come. This allows our clients to make the right decisions, as they are well informed of their current situation and can lean on fme’s extensive knowledge in digital transformations, as their strategic technical partner.

More about us – It’s fme you love to work with

fme proudly focus on enabling delivery excellence for our clients, one of the many reasons why the world’s leading life sciences firms trust us with their most complex quality, regulatory, and clinical transformations. We deliver to the same high standards they follow, holding ISO/IEC 27001 QMS and ISO 9001:2015 certifications.

Your data migration deserves the best start. 

Download our datasheet below to explore fme’s end-to-end platform capabilities and see how our expertise can guide your transition.

A Start Smart For Your Migration Can Start Today

Our experts are ready to help you start building your migration strategy today, to ensure data integrity, compliance, and business continuity—while setting your organization up for long-term success.

About the Author

Lucas Gent, PhD., Project Manager

Lucas Gent is one of fme’s exceptional project managers bringing a remarkable blend of scientific rigor, regulatory expertise, and project leadership to the team. He holds a Molecular Genetics PhD and is a Prince2, Scrum Master certified project manager, most recently serving within Reckitt Benckiser’s Global Professional R&D division. He is a daily user of Vault, bringing hands-on experience across technical, quality and procurement functions. He is also a seasoned Vault QualityDocs user with a clear understanding of document lifecycle management.